APA

Chen J. C. C., Sumner R. L., Krishnamurthy Naga V., Hoeh N., Ayeni H. A., Singh V., Sundram F., Campbell D. & Muthukumaraswamy S. (20201207). A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder. : Trials.

Chicago

Chen Joseph C C, Sumner Rachael L, Krishnamurthy Naga Venkat, Hoeh Nicholas, Ayeni Hafis Adetokunbo, Singh Vikrant, Sundram Frederick, Campbell Douglas and Muthukumaraswamy Suresh. 20201207. A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder. : Trials.

Harvard

Chen J. C. C., Sumner R. L., Krishnamurthy Naga V., Hoeh N., Ayeni H. A., Singh V., Sundram F., Campbell D. and Muthukumaraswamy S. (20201207). A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder. : Trials.

MLA

Chen Joseph C C, Sumner Rachael L, Krishnamurthy Naga Venkat, Hoeh Nicholas, Ayeni Hafis Adetokunbo, Singh Vikrant, Sundram Frederick, Campbell Douglas and Muthukumaraswamy Suresh. A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder. : Trials. 20201207.